Medtronic enrolls first patient in head-to-head aortic stent graft trial
Medtronic (NYSE:MDT) today announced that it enrolled the first patient in a head-to-head trial of aortic stent graft systems.
Source: massdevice.com
Stay updated with breaking news from Gore Excluder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic (NYSE:MDT) today announced that it enrolled the first patient in a head-to-head trial of aortic stent graft systems.